HOME >> BIOLOGY >> NEWS
JCI table of contents, March 9, 2006

d LY2108491 and LY2109866, and found that mice treated with these compounds developed increased thickness of the epidermal layer of their skin, a model which suggests that the compounds will inhibit psoriasis-related symptoms in humans. Using isolated human cells in laboratory dishes, the authors also showed that these compounds have potent action in other target cells such as keratinocytes of the skin, osteoblasts of bone, and blood cells. Further work on these and related compounds may lead to the development of potent treatments for cancers, psoriasis, and osteoporosis that have fewer unwanted side effects.

TITLE: Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators

AUTHOR CONTACT: Sunil Nagpal
Eli Lilly and Company, Indianapolis, Indiana, USA
Phone: (484) 865-5627; Fax: (484) 865-9389; E-mail: nagpals@wyeth.com
View the PDF of this article at: https://www.the-jci.org/article.php?id=25901

NEPHROLOGY

Human gene mutation causes kidney stones and kidney failure

Mutations in a human gene known as Claudin16 are responsible for certain causes of kidney failure and kidney stones, and increased urine calcium and magnesium levels. However, the precise effects that these different mutations have on claudin16 protein structure and biological action are unclear. Now, in a study appearing online on March 9 in advance of print publication in the April issue of the Journal of Clinical Investigation, Walter Hunziker and colleagues from the Institute of Molecular and Cell Biology in Singapore have identified that the majority of mutations in claudin16, which is normally located on the surface of kidney cells, cause the protein to get stuck inside the cells or get degraded by the cell's own protein-destroying machinery. The researchers created 2
'"/>

Contact: Brooke Grindlinger
press_releases@the-jci.org
212-342-9006
Journal of Clinical Investigation
9-Mar-2006


Page: 1 2 3 4 5 6

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/22/2020)... ... January 21, 2020 , ... Modality ... supporting global regulatory applications, and executing global clinical trial operations. Milestone highlights ... a fastest growing company, and ISO 9001:2015 certification with the scope of ...
(Date:1/2/2020)... ... January 02, 2020 , ... ... reagents, chemicals, and medias, as well as medical grade plastic products to the ... product manufacturers. , “We are excited to bring even more advantages and ...
(Date:12/21/2019)... ... 2019 , ... The City of Tampa recently served as the host location ... these heroes. Tampa welcomed these most-highly decorated USA heroes as the National Hockey League ... distinguished service members. , The Medal of Honor, the USA military’s highest award for ...
Breaking Biology News(10 mins):
(Date:12/27/2019)... ... December 27, 2019 , ... Leak ... instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries is excited ... . Following acquisition by CLJ Holdings in February, 2019, a comprehensive and aggressive ...
(Date:12/18/2019)... ... December 17, 2019 , ... Innovative Health, ... reprocessing Electrophysiology (EP) devices since the company’s inception in 2016. This marks a ... (a Johnson & Johnson company) have received 2 and 4 EP device clearances, ...
(Date:12/14/2019)... ... December 12, 2019 , ... ... leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging Industries ... LDA LT80 (LOW TEMPERATURE -80C) helium leak testing system is designed for testing ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... and services, today announced a partnership with the Recombinant Antibody Network (RAN), a ... and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies ...
Breaking Biology Technology:
Cached News: